rs141382970
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
This summary comes from the ClinGen Evidence Repository: The c.748C>T p.Arg250Cys variant in MECP2 (NM_004992.3) is present in 1 XY and 4 XX individuals in gnomAD (0.0034% in the European non-Finnish population) (not sufficient to meet BS1 criteria). The p.Arg250Cys variant is observed in at least 2 unaffected individuals (GeneDx internal data) (BS2). The p.Arg250Cys variant has been observed in at least 1 individual with RTT-like disease (PMID 30405208); however PS4 cannot be applied at any strength due to the gnomAD frequency. Computational prediction analysis tools are inconclusive for this variant (criteria not met). Alternative missense variants (p.Arg250Gly and p.Arg250His) have previously been identified within this codon, however they are not considered to be pathogenic variants (PMID 30405208; RettBASE: RettSyndrome.org Variation Database mecp2.chw.edu.au). In the absence of conflicting evidence, this is sufficient evidence to classify as likely benign based on the specifications defined by the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. In summary, the c.748C>T p.Arg250Cys variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA205183/MONDO:0010726/036
Frequency
Consequence
ENST00000453960.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.784C>T | p.Arg262Cys | missense_variant | 3/3 | ENST00000453960.7 | NP_001104262.1 | |
MECP2 | NM_004992.4 | c.748C>T | p.Arg250Cys | missense_variant | 4/4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960.7 | c.784C>T | p.Arg262Cys | missense_variant | 3/3 | 1 | NM_001110792.2 | ENSP00000395535 | ||
MECP2 | ENST00000303391.11 | c.748C>T | p.Arg250Cys | missense_variant | 4/4 | 1 | NM_004992.4 | ENSP00000301948 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000887 AC: 1AN: 112767Hom.: 0 Cov.: 23 AF XY: 0.0000286 AC XY: 1AN XY: 34911
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 182990Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67600
GnomAD4 exome AF: 0.0000474 AC: 52AN: 1098086Hom.: 0 Cov.: 35 AF XY: 0.0000578 AC XY: 21AN XY: 363450
GnomAD4 genome AF: 0.00000887 AC: 1AN: 112767Hom.: 0 Cov.: 23 AF XY: 0.0000286 AC XY: 1AN XY: 34911
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2019 | See Variant Classification Assertion Criteria. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 09, 2018 | The MECP2 c.748C>T; p.Arg250Cys variant (rs141382970), to our knowledge, has not been reported in the medical literature but is reported as benign by one laboratory in ClinVar (Variation ID: 211466). This variant is observed in the general population at an overall frequency of 0.002% (5/178458 alleles, including 1 hemizygote) in the Genome Aggregation Database. The arginine at codon 250 is highly conserved, and computational algorithms (PolyPhen2, SIFT) predict this variant to be deleterious. However, additional variants at this codon (p.Arg250Arg, p.Arg250His) are considered as polymorphisms that do not cause disease (see link for Rett database). Due to limited information regarding this variant, its clinical significance cannot be determined with certainty. References: Link to Rett database: http://mecp2.chw.edu.au/cgi-bin/mecp2/views/basic.cgi?form=basic - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2021 | - - |
Severe neonatal-onset encephalopathy with microcephaly Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 250 of the MECP2 protein (p.Arg250Cys). This variant is present in population databases (rs141382970, gnomAD 0.006%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of MECP2-related conditions (PMID: 30405208). ClinVar contains an entry for this variant (Variation ID: 211466). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MECP2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
MECP2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 22, 2024 | The MECP2 c.748C>T variant is predicted to result in the amino acid substitution p.Arg250Cys. This variant has been reported in a patient with a MECP2 related disorder; however, no additional studies confirmed its pathogenicity (Zhang et al. 2019. PubMed ID: 30405208). This variant is reported in 0.0063% of alleles in individuals of European (Finnish) descent in gnomAD. It has been detected in the heterozygous and hemizygous states in both the gnomAD database and the PreventionGenetics internal database at a frequency that is higher than expected for a disease-causing MECP2 variant, and is observed in individuals not expected to have a MECP2-related disease. Alternate missense changes at the same amino acid position have been reported in gnomAD, and as non-disease-causing variants in the Rett database (http://mecp2.chw.edu.au/cgi-bin/mecp2/views/basic.cgi?form=basic; https://gnomad.broadinstitute.org/region/X-153296511-153296551). This variant has conflicting classifications in ClinVar of Uncertain, Likely Benign, and Benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/211466/). Although we suspect this variant is benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Rett syndrome Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Dec 06, 2023 | The c.748C>T p.Arg250Cys variant in MECP2 (NM_004992.3) is present in 1 XY and 4 XX individuals in gnomAD (0.0034% in the European non-Finnish population) (not sufficient to meet BS1 criteria). The p.Arg250Cys variant is observed in at least 2 unaffected individuals (GeneDx internal data) (BS2). The p.Arg250Cys variant has been observed in at least 1 individual with RTT-like disease (PMID 30405208); however PS4 cannot be applied at any strength due to the gnomAD frequency. Computational prediction analysis tools are inconclusive for this variant (criteria not met). Alternative missense variants (p.Arg250Gly and p.Arg250His) have previously been identified within this codon, however they are not considered to be pathogenic variants (PMID 30405208; RettBASE: RettSyndrome.org Variation Database mecp2.chw.edu.au). In the absence of conflicting evidence, this is sufficient evidence to classify as likely benign based on the specifications defined by the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. In summary, the c.748C>T p.Arg250Cys variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2). - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at